Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
Godet C, Couturaud F, Marchand-Adam S, Pison C, Gagnadoux F, Blanchard E, Taillé C, Philippe B, Hirschi S, Andréjak C, Bourdin A, Chenivesse C, Dominique S, Bassinet L, Murris-Espin M, Rivière F, Garcia G, Caillaud D, Blanc FX, Goupil F, Bergeron A, Gondouin A, Frat JP, Flament T, Camara B, Priou P, Brun AL, Laurent F, Ragot S, Cadranel J; NebuLamB study group and GREPI network; Godet C, Couturaud F, Cadranel J, Frat JP, Brun AL, Laurent F, Marchand-Adam S, Pison C, Gagnadoux F, Blanchard E, Taillé C, Philippe B, Hirschi S, Andréjak C, Chenivesse C, Dominique S, Bassinet L, Murris-Espin M, Rivière F, Garcia G, Caillaud D, Blanc FX, Goupil F, Gondouin A, Flament T, Camara B, Priou P, Ragot S. Godet C, et al. Among authors: chenivesse c. Eur Respir J. 2022 Jun 16;59(6):2102218. doi: 10.1183/13993003.02218-2021. Print 2022 Jun. Eur Respir J. 2022. PMID: 34764182 Free article. Clinical Trial.
Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic.
Morélot-Panzini C, Adler D, Aguilaniu B, Allard E, Bautin N, Beaumont M, Blanc FX, Chenivesse C, Dangers L, Delclaux C, Demoule A, Devillier P, Didier A, Georges M, Housset B, Janssens JP, Laveneziana P, Laviolette L, Muir JF, Ninot G, Perez T, Peiffer C, Schmidt M, Similowski T, Straus C, Taillé C, Van Den Broecke S, Roche N; dyspnoea working group of the Société de Pneumologie de Langue Française. Morélot-Panzini C, et al. Among authors: chenivesse c. Eur Respir J. 2017 Sep 27;50(3):1701159. doi: 10.1183/13993003.01159-2017. Print 2017 Sep. Eur Respir J. 2017. PMID: 28954773 Free article. No abstract available.
Clinical and economic burden of severe asthma: A French cohort study.
Nordon C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, Amzal B, Thabut G, Marthan R, Aubier M; COBRA Study Group. Nordon C, et al. Respir Med. 2018 Nov;144:42-49. doi: 10.1016/j.rmed.2018.10.002. Epub 2018 Oct 2. Respir Med. 2018. PMID: 30366583 Free article.
How can we minimise the use of regular oral corticosteroids in asthma?
Bourdin A, Adcock I, Berger P, Bonniaud P, Chanson P, Chenivesse C, de Blic J, Deschildre A, Devillier P, Devouassoux G, Didier A, Garcia G, Magnan A, Martinat Y, Perez T, Roche N, Taillé C, Val P, Chanez P. Bourdin A, et al. Among authors: chenivesse c. Eur Respir Rev. 2020 Feb 5;29(155):190085. doi: 10.1183/16000617.0085-2019. Print 2020 Mar 31. Eur Respir Rev. 2020. PMID: 32024721 Free PMC article. Review.
Aberrant anti-viral response of natural killer cells in severe asthma.
Devulder J, Chenivesse C, Ledroit V, Fry S, Lobert PE, Hober D, Tsicopoulos A, Duez C. Devulder J, et al. Among authors: chenivesse c. Eur Respir J. 2020 May 14;55(5):1802422. doi: 10.1183/13993003.02422-2018. Print 2020 May. Eur Respir J. 2020. PMID: 32108047 Free article.
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohort.
Dupin C, Belhadi D, Guilleminault L, Gamez AS, Berger P, De Blay F, Bonniaud P, Leroyer C, Mahay G, Girodet PO, Raherison C, Fry S, Le Bourdellès G, Proust A, Rosencher L, Garcia G, Bourdin A, Chenivesse C, Didier A, Couffignal C, Taillé C. Dupin C, et al. Among authors: chenivesse c. Clin Exp Allergy. 2020 Jul;50(7):789-798. doi: 10.1111/cea.13614. Epub 2020 May 29. Clin Exp Allergy. 2020. PMID: 32469092 Clinical Trial.
Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study.
Suehs CM, Zysman M, Chenivesse C, Burgel PR, Couturaud F, Deslee G, Berger P, Raherison C, Devouassoux G, Brousse C, Roche N, Molimard M, Chinet T, Devillier P, Chanez P, Kessler R, Didier A, Martinat Y, Le Rouzic O, Bourdin A. Suehs CM, et al. Among authors: chenivesse c. BMJ Open. 2020 Jul 1;10(7):e035811. doi: 10.1136/bmjopen-2019-035811. BMJ Open. 2020. PMID: 32611741 Free PMC article.
Management of asthma during the Coronavirus disease 2019 outbreak.
Taillé C, Chenivesse C, Devouassoux G, Bourdin A, Garcia G; G2A Groupe Asthme et Allergie; French Language Respiratory Society SPLF Société de Pneumologie de Langue Francaise. Taillé C, et al. Among authors: chenivesse c. Respir Med Res. 2020 Nov;78:100762. doi: 10.1016/j.resmer.2020.100762. Epub 2020 May 25. Respir Med Res. 2020. PMID: 32805635 Free PMC article. No abstract available.
121 results